Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality | Zendy

Xiaoye Zhu | Zendy; Pim J. van Leeuwen | Zendy; Erik Holmberg | Zendy; Meelan Bul | Zendy; Sigrid Carlsson | Zendy; Fritz H. Schröder | Zendy; Monique J. Roobol | Zendy; Jonas Hugosson | Zendy

Open Access

Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality

Author(s) -

Xiaoye Zhu,

Pim J. van Leeuwen,

Erik Holmberg,

Meelan Bul,

Sigrid Carlsson,

Fritz H. Schröder,

Monique J. Roobol,

Jonas Hugosson

Publication year - 2012

Publication title -

journal of medical screening

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.515

H-Index - 64

eISSN - 1475-5793

pISSN - 0969-1413

DOI - 10.1258/jms.2012.012071

Subject(s) - medicine , randomization , informed consent , incidence (geometry) , prostate cancer , randomized controlled trial , cumulative incidence , cancer , clinical trial , mortality rate , cohort , alternative medicine , pathology , physics , optics

To assess the impact of different study designs on outcome data within the European Randomized Study of Screening for Prostate Cancer (ERSPC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research